As researchers urgently work to develop vaccines to prevent COVID-19, many strategies have been considered. Now, a parainfluenza virus 5-based vaccine expressing MERS-CoV spike protein may provide an avenue for a COVID-19 vaccine based on the similarity of the two viruses, according to a study published in mBio on April 7. Discuss
Biopharmaceutical New Technologies (BioNTech) and Pfizer have released additional details regarding their collaboration to advance the mRNA COVID-19 vaccine candidate BNT162. Pfizer will pay up to $748 million to BioNTech.
Avectas has received a patent for its Solupore cell engineering technology.
Almost half of all scientific research labs that participated in a recent survey were shut down due to concerns about the COVID-19 outbreak. Survey results indicate that scientists are quite concerned and that their work is considerably impacted by the pandemic, according to a new COVID-19 scientist sentiment tracker. Discuss
After deciding to postpone its annual scientific meeting due to COVID-19, The American Association for Clinical Chemistry (AACC) has rescheduled the meeting and clinical lab expo for December 13-17 in Chicago
Within four weeks of the SARS-CoV-2 spike sequence becoming available, researchers from the University of Pittsburgh School of Medicine developed immunogens for a potential COVID-19 vaccine. The vaccine is delivered through a fingertip-sized patch, and it produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing the virus, according to the April 2 EBioMedicine publication. Discuss
The divestment of GE's BioPharma business unit to Danaher is complete, according to an announcement by both companies on March 31.
Bruker is showcasing a number of its new analytical systems and other products for biopharma and forensics applications. The products include a new gas analyzer as well as a benchtop x-ray elemental analyzer.
Vycellix and Avectas have unveiled plans to collaborate on the development of cell-based immunotherapeutic products.
A new method called genetically targeted chemical assembly (GTCA) has demonstrated the ability to build artificial structures within the body to carry out unique functions. The research, presented in the latest edition of Science, provides compelling evidence for GTCA's ability to modify cell function with bioengineering tools. Discuss
Conferences
2nd Annual Cell Therapy Bioprocessing Conference
June 25-26
Boston, Massachusetts United States
June 25-26
Boston, Massachusetts United States
BioProcess International Europe
July 13-16
Amsterdam, Noord-Holland Netherlands
July 13-16
Amsterdam, Noord-Holland Netherlands
Bioprocess International West
August 10-13
Santa Clara, California United States
August 10-13
Santa Clara, California United States
BioProcess International
September 21-24
Boston, Massachusetts United States
September 21-24
Boston, Massachusetts United States
Japan Analytical & Scientific Instruments Show (JASIS)
November 11-13
Chiba, Chiba Japan
November 11-13
Chiba, Chiba Japan
|
General Discussion
|
||
| Topic | Replies / Views | Last Update |
|---|---|---|
|
Open science for the modern scientific community
|
3 / 53 | More than 3 days ago |
|
https://academic.oup.com/ve/pages/coronavirus-evolution
|
0 / 14 | More than 3 days ago |
|
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
|
0 / 8 | More than 3 days ago |
|
Engineered Bacteria Produces BeeFree Honey
|
0 / 11 | More than 3 days ago |
|
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
|
0 / 14 | More than 3 days ago |
| To see more posts from our community or to share a post of your own, go to our community's forum page. | ||
Insights
Exclusive content for Science Advisory Board members on trends and outcomes that are influencing the future of scientific research.
Communities
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Rewards
Earn points for contributing to research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Connect
